Company

eXoZymes (Nasdaq: EXOZ)

Biotechnology Monrovia, California, United States 38 employees EXOZ

Employees: 38
Contacts: 4
Emails: 4
Phones: 4

www.invizyne.com LinkedIn

eXoZymes (Nasdaq: EXOZ) Overview

Headquarters: Monrovia, California, United States
Website: www.invizyne.com
Industry: Biotechnology
Employees: 38
Founded: 2014
Stock Symbol: EXOZ

Keywords

synthetic biology SynBio cell free biotechnology biomanufacturing natural chemicals enzymatic pathways chemicals pharmaceuticals cannabinoids

About eXoZymes (Nasdaq: EXOZ)

Nature provides us with countless chemicals that can improve our lives. Trees and plants often supply them, but in such small amounts that they’re hard to extract, leading to waste and environmental degradation. To harness natural chemicals more effectively, synthetic biology first attempted to rewire living cells to make them easier to extract. But cells are complicated and not easily rewired. Invizyne’s new approach, SimplePath streamlines synthetic biology by removing cells altogether, along with their complexities. Using our proprietary, sustainable enzyme systems we can build simple, efficient reactors for chemical production.

eXoZymes (Nasdaq: EXOZ) Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

eXoZymes (Nasdaq: EXOZ) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Edgar Sur	Operations I Supply Chain I Operational	Irvine, California, United States	Email Phone
Sanjeev Srivastava	Investment Manager - Capital Markets	New York City Metropolitan Area, United States	Email Phone
Michael Heltzen	Enzymes X AI = Exozymes. CEO @ Exozymes	United States	Email Phone
Jim Lalonde	Board Member, Senior Advisor	San Francisco Bay Area, United States	Email Phone